Hangzhou Sumgen Biotech Co., Ltd. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1 | 2 | |
| Phase 1/2 | 2 | |
| Phase 2 | 3 | |
| Phase 3 | 1 |
Disease areas by active trials
Multiple Myeloma (3) · Lupus (SLE) (1)
Get alerts when Hangzhou Sumgen Biotech Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.